Post by Effectum Medical AG

Pharma companies navigate complex regulations every day. So why do combination products under EU MDR keep catching experienced teams off guard? Our CEO Karina Candrian broke down the 5 reasons In her article here: https://lnkd.in/e_NaWYXP Here’s the recap:  • Post-Market Surveillance - an ongoing system, not a one-time submission • In-house device capabilities pull focus from core pharma strengths • CE marking demands sustained expertise - long after certification • One compliant QMS is hard. You might need two. • Device-specific requirements ≠ what pharma teams know - learning about them mid-submission gets expensive Swipe for the full picture And the one decision that gets you out of all 5 ;) #EUMDR #CombinationProducts #MedicalDevices #Pharma